iBio
IBIO
#10074
Rank
S$34.96 M
Marketcap
S$1.56
Share price
-6.25%
Change (1 day)
-55.14%
Change (1 year)

iBio (IBIO) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : S$10.76 Million

According to iBio's latest financial reports the company's total liabilities are S$10.76 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

iBio - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30S$10.03 M-71.25%
2023-06-30S$34.91 M-30.07%
2022-06-30S$49.93 M-3.29%
2021-06-30S$51.63 M-1.41%
2020-06-30S$52.37 M37.74%
2019-06-30S$38.02 M3.64%
2018-06-30S$36.68 M-1.64%
2017-06-30S$37.29 M0.48%
2016-06-30S$37.12 M2081.37%
2015-06-30S$1.7 M245.57%
2014-06-30S$0.49 M-90.95%
2013-06-30S$5.43 M19.37%
2012-06-30S$4.55 M-47.99%
2011-06-30S$8.76 M63.71%
2010-06-30S$5.35 M583.4%
2009-06-30S$0.78 M-94.1%
2008-06-30S$13.27 M6.79%
2007-06-30S$12.42 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Genocea Biosciences
GNCA
S$34.21 M 217.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$1.13 B 10,477.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$147.13 B 1,367,016.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S$0.28 B 2,503.99%๐Ÿ‡บ๐Ÿ‡ธ USA